Related Links
Current Releases
Stock Quote
Standard & Poor's
SEC Filings
Mailing List
Releases Archives
Opexa Therapeutics Headlines
09/13/2007 - 02:38 PM
Opexa Therapeutics to Present at the First Annual Maxim Group Growth Conference
09/11/2007 - 07:30 AM
Opexa Therapeutics Gives Update on Phase IIb Trial of Tovaxin(R) for Treatment of Multiple Sclerosis
08/23/2007 - 07:00 AM
Opexa to Present Proprietary T-Cell Technology at Vaccine Conference on August 24, 2007
08/14/2007 - 10:49 AM
Opexa Reports Second Quarter 2007 Financial Results
08/08/2007 - 07:00 AM
Opexa Therapeutics Receives European Patent Notification for T-Cell Vaccine
06/27/2007 - 11:02 AM
Opexa Advances Monocyte Derived Islet Technology to Proof of Principle in stz-induced NOD/SCID Mice
06/21/2007 - 09:19 AM
Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin(TM) for Multiple Sclerosis
06/11/2007 - 07:00 AM
Opexa Presents Tovaxin(TM) Research at Federation of Clinical Immunology Societies Annual Meeting
05/22/2007 - 07:00 PM
Opexa Therapeutics Appoints Clinical Advisory Board to Support Diabetes Program
05/22/2007 - 07:00 AM
Opexa Therapeutics Appoints Dr. Mark Pittenger, Prominent Stem-Cell Researcher, to Scientific Advisory Board
05/17/2007 - 07:00 AM
Opexa Therapeutics Completes Patient Enrollment in Phase IIb Trial of Tovaxin(TM) for Treatment of Multiple Sclerosis
05/15/2007 - 07:00 AM
Opexa Reports First Quarter 2007 Results
05/07/2007 - 07:00 AM
Opexa Therapeutics to Present Progress on Development of Monocyte-Derived Pancreatic Islet Cells for Diabetes
05/04/2007 - 07:00 AM
Opexa Therapeutics to Present at BIO 2007 Business Forum
04/03/2007 - 07:00 AM
Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Dose Escalation Trial with Tovaxin(TM) for Multiple Sclerosis
03/19/2007 - 07:30 AM
Opexa Therapeutics to Be Featured in Live MN1.com Interview
03/19/2007 - 07:00 AM
Opexa Reports Year End 2006 Financial Results
02/16/2007 - 07:00 AM
Opexa Therapeutics to Present at the Roth Capital Partners 19th Annual OC Conference
02/14/2007 - 11:31 AM
Opexa Therapeutics Launches Tovaxin(TM) Clinical Trial Website for Multiple Sclerosis
02/06/2007 - 07:30 AM
Opexa Announces Encouraging Clinical Data on Novel T-Cell Vaccination Therapy for Rheumatoid Arthritis
01/30/2007 - 07:00 AM
Opexa Achieves Midpoint in Patient Admissions in Phase IIb Trial of Tovaxin(TM) for Multiple Sclerosis
11/29/2006 - 08:38 AM
Opexa Therapeutics to Present at BMO Capital Markets Focus on Healthcare Conference
11/13/2006 - 08:00 AM
Opexa Reports Third Quarter Financial Results
11/06/2006 - 07:00 AM
Opexa Begins Dosing Patients in Phase IIb Trial of Tovaxin(TM) for Multiple Sclerosis
10/31/2006 - 07:00 AM
Opexa Therapeutics to Present at Rodman & Renshaw Eighth Annual Healthcare Conference
1
2
3
4
5
« Previous
Next »
Releases Archives
